New incident report
Incident Report Number: 2010-0572
Registrant Reference Number: Prosar 1-21221272
Registrant Name (Full Legal Name no abbreviations): Syngenta Crop Protection Canada, Inc.
Address: 140 Research Lane, Research Park
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G4Z3
Domestic Animal
Country: UNITED STATES
Prov / State: KENTUCKY
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: Warrior (non-specific)
Liquid
Yes
Unknown
Site: Agricultural-Outdoor/Agricole-extérieur
Préciser le type: Unknown
Unknown
Medical Professional
Horse / Cheval
Unknown breed
1
Unknown
Unknown
Unknown
Unknown
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
Unknown
Unknown
Died
Other / Autre
specify Potential contact with treated area
(eg. description of the frequency and severity of the symptoms
1-21221272: A reporter (veterinarian) called on 01/04/2010 to report the possible exposure of 4 horses to an insecticide containing the active ingredient Lambda-cyhalothrin. According to the reporter, foliage was sprayed with the product via airplane about 3 months prior to the report (approximately 10/2009). The horses potentially had inhalation and dermal exposure, and may also have eaten treated vegetation. Two months prior to the report (11/2009), Horse #1 (1st Subform III) developed acute colic and died. The other 3 horses (2nd Subform III) have had poor appetites and chronic intermittent colic. All 3 horses have blood work results that appear consistent with a viral infection. Blood work abnormalities include lymphocytosis, monocytosis, and neutropenia. The reporter was advised that the products contain the active ingredient in concentrations ranging from 11% to 22%. These products are typically diluted prior to application. Inhalation and dermal exposure to the products may result in irritation. Paraesthesia is possible following dermal exposure. Inhalation may lead to more pronounced signs in an animal with underlying respiratory issues such as COPD or heaves. Signs of irritation would be expected to develop immediately following exposure. Ingestion of significant amounts of concentrated product may result in neurologic signs such as tremors and seizures soon after exposure. Hematologic abnormalities are not expected following product exposure of any kind, and a recommendation was made to consider other causes for the horses' signs. No further information was obtained.
Death
The symptoms were not consistent with exposure to Lambda-Cyhalothrin
Medical Professional
Horse / Cheval
Unknown breed
3
Unknown
Unknown
Unknown
Unknown
Unknown / Inconnu
Unknown / Inconnu
System
Unknown / Inconnu
Unknown
Unknown
Unknown/Inconnu
Other / Autre
specify Possible contact with treated area
(eg. description of the frequency and severity of the symptoms
1-21221272: A reporter (veterinarian) called on 01/04/2010 to report the possible exposure of 4 horses to an insecticide containing the active ingredient Lambda-cyhalothrin. According to the reporter, foliage was sprayed with the product via airplane about 3 months prior to the report (approximately 10/2009). The horses potentially had inhalation and dermal exposure, and may also have eaten treated vegetation. Two months prior to the report (11/2009), Horse #1 (1st Subform III) developed acute colic and died. The other 3 horses (2nd Subform III) have had poor appetites and chronic intermittent colic. All 3 horses have blood work results that appear consistent with a viral infection. Blood work abnormalities include lymphocytosis, monocytosis, and neutropenia. The reporter was advised that the products contain the active ingredient in concentrations ranging from 11% to 22%. These products are typically diluted prior to application. Inhalation and dermal exposure to the products may result in irritation. Paraesthesia is possible following dermal exposure. Inhalation may lead to more pronounced signs in an animal with underlying respiratory issues such as COPD or heaves. Signs of irritation would be expected to develop immediately following exposure. Ingestion of significant amounts of concentrated product may result in neurologic signs such as tremors and seizures soon after exposure. Hematologic abnormalities are not expected following product exposure of any kind, and a recommendation was made to consider other causes for the horses' signs. No further information was obtained.
Moderate